BMY vs SD · P/E 17, rev $48.19B vs P/E 6.9, rev $125.3M
Bristol-Myers Squibb Company (BMY) versus SandRidge Energy Inc (SD) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
SandRidge Energy Inc (SD) is a oil & gas e&p company listed on NYSE.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported SD revenue for 2024-12-31 was $125.3M. Net income was $63.0M. Revenue was down 15.7% from 2023-12-31 to 2024-12-31. SD currently screens at market cap $522.0M and trailing P/E 6.9.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. SD currently screens at market cap $522.0M and trailing P/E 6.9.
Not investment advice. Open the BMY and SD stock pages for the full models.
Not investment advice.